“The monotherapy group included 65% of patients with previous HPV compared to 29% in the combination arm, so there was a clear bias in favour of the monotherapy arm.”
Found this statement to be very interesting regarding in particular pdl1 negative expressor data results.
The monotherapy arm had patients who were in better health then the combo arm.
Mono arm (Keytruda)
”these patients are generally healthier and do not suffer from co-morbidities associated with smoking and alcohol abuse. “
Media, page-72
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.3¢ |
Change
-0.003(0.62%) |
Mkt cap ! $581.0M | |||
| Open | High | Low | Value | Volume |
| 40.5¢ | 40.5¢ | 39.5¢ | $174.9K | 436.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 97990 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 235006 | 13 |
View Market Depth
| Last trade - 11.46am 10/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |